CSL Limited (ASX: CSL) is Australia’s largest (and some might say best) healthcare company, specialising in biopharmaceuticals. Founded in the late 1900s as the Commonwealth Serum Laboratories, CSL was sold by the Australian Government to Australian investors via the share market in 1994 at $2.30 per share, at which time it doubled its size through an international acquisition. CSL is a global leader in blood plasma vaccines (think: the flu) and antivenoms, providing relief for potentially life-threatening medical conditions.
The S&P/ASX 200 (INDEXASX:XJO) is set to open lower on Wednesday. Nuix (ASX:NXL) and Fortescue (ASX:FMG) shares are in the news.
The S&P/ASX 200 (INDEXASX:XJO) finished Friday on a positive note. The Kogan (ASX:KGN) share price is making headlines.
There are a number of reasons to consider looking at CSL Limited (ASX:CSL) at the current share price. Its R&D program is really good.
The S&P/ASX 200 (INDEXASX:XJO) followed Wall Street lower on Thursday. Xero (ASX:XRO) and Perenti (ASX:PRN) shares are in the news.
The S&P/ASX 200 (INDEXASX:XJO) reached a 14-month high on Wednesday. ANZ (ASX:ANZ) and Nearmap Ltd (ASX:NEA) shares are in the news.
The Mayne Pharma Group Ltd (ASX: MYX) share price soared by 17% last Friday but has dropped slightly today. What’s happening with Mayne Pharma share price?
BetaShares Australia 200 ETF (ASX: A200) might be one of the best ways to invest into ASX shares such as Commonwealth Bank of Australia (ASX:CBA).
The Altium Limited (ASX: ALU) share price has risen by as much as 5% today. What do I monitor when the Altium share price jumps?
In this article you’ll find two tips to invest better on the ASX. Plus, a chance to get two pineapples off Rask’s premium member services.
